JAZZ - Company ID 0001232524
The table below shows Jazz Pharmaceuticals plc's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.39B | $2.41B | $1.51B | $881.48M | $591.45M | $1.06B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $830.75M | $716.76M | $705.79M | $651.49M | $563.36M | $396.49M |
| Inventory | $416.96M | $480.44M | $597.04M | $714.06M | $1.07B | $95.40M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $4.17B |
| $4.63B |
| $3.44B |
| $2.61B |
| $2.61B |
| $2.84B |
| Property, plant & equipment | - | - | - | - | - | $127.94M |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958.30M |
| Total assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B |
| Accounts payable | $122.06M | $77.87M | $102.75M | $90.76M | $100.30M | $26.95M |
| Total current liabilities | $2.24B | $1.04B | $1.54B | $933.19M | $809.30M | $653.75M |
| Long-term debt | $4.33B | $6.08B | $5.11B | $5.69B | $6.02B | $1.85B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $646.18M | $1.13B | $878.66M | $733.59M | $830.23M | $1.16B |
| Total equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B |